Observ Medical

[TekBot]

Observe Medical ASA - Mandatory notification of trade

15 March 2024, Observe Medical ASA (the “Company”): Soleglad Invest AS (a
closely related party to Kathrine Gamborg Andreassen, director of the board of
directors in the Company), has on 15 March 2024 sold 200,000 shares in the
…

Vis børsmeldingen

Company at a price of NOK 0.42.

Following the sale, Soleglad Invest AS holds 618,760 shares in the Company. Copy
of notification is attached hereto.

Kilde

[Powertrade]

Hvor går veien i dag…. Innsidesalg…… hmm

[Powertrade]

Hold ut… snart 1 krone her

[Powertrade]

Observe er på vei opp av bunn. Vennligst ta plass og fest sikkerhetsbelte . Veien opp er lang- men opp skal det

Sterkt at vi har klatret gjennom 0,4 og er på vei til 0,5 nå. Første stopp er 1,0 før sommeren

100%

Blir dere med opp?

[Quadruple]

Håper vi ikke begynner å få Hegnar-tilstander her?

[TekBot]

Observe Medical - CFO resignation

Oslo, March 21, 2024 - Observe Medical ASA (the “Company” or “Observe Medical”)
announces that Per Arne Nygård has resigned from his position as CFO in order to
pursue opportunities outside of the Company.
…

Vis børsmeldingen

Johan Fagerli, the current Finance Manager, will assume the responsibilities of
Interim CFO effective immediately. Mr. Fagerli has been with the Company since
2021 and brings extensive experience and a deep understanding of our financial
operations, ensuring a smooth transition and continued strategic financial
management.

We look forward to Mr. Fagerli’s leadership in his new role as we continue to
execute our strategic objectives.

For further information, please contact:

Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, Finance Manager Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available at www.observemedical.com.

Kilde

[Quadruple]

Nygård virket å være en bra mann for selskapet. Men forståelig at han går for noe annet.

[Powertrade]

Kanskje april byr på nye kontrakter og spennende nyheter.

[TekBot]

Observe Medical transfers Nordic distribution to Vingmed

Oslo, April 18, 2024 - Observe Medical ASA (the “Company” or “Observe Medical”)
announces transfer of its Nordic distribution operations to Vingmed, following a
strategic review. The Company assessed the relevance of the business, originally
…

Vis børsmeldingen

established as a platform for testing and launching its branded products.

Given the expansion of our global distribution capabilities, which now fulfill
our initial testing and pre-launch needs, the business is becoming less crucial
to our core operations. Consequently, we have decided to seek more suitable
ownership of the Nordic operations going forward.

In November 2023, this decision aligned with the establishment of a new
distribution partnership agreement with Vingmed for the UnoMeterT portfolio in
the Nordic region. Subsequent to this agreement, we began confidential
discussions with Vingmed that resulted in a formal agreement to transfer our
Nordic distribution business to them. The planning for this transfer started in
late 2023 under strict confidentiality to safeguard the ongoing business
operations.

As we now approach the final stages of this transition, we are lifting the
confidentiality to transparently communicate with our stakeholders. The
completion of this transfer is anticipated by the second quarter of 2024. This
strategic divestiture aligns with Observe Medical’s broader objective to
streamline our operations and concentrate on expanding our international market
presence, thereby enhancing shareholder value and strengthening our competitive
position in the global market.

For further information, please contact:

Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, Interim CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available at www.observemedical.com.

Kilde

[Powertrade]

Bra nyheter

Måtte kursen stige

Blir spennnede med 1Q salget

[Quadruple]

Hva synes du er bra?

[Powertrade]

This
strategic divestiture aligns with Observe Medical’s broader objective to
streamline our operations and concentrate on expanding our international market
presence, thereby enhancing shareholder value and strengthening our competitive
position in the global market.

[Quadruple]

@Powertrade

concentrate on expanding our international market
presence, thereby enhancing shareholder value and strengthening our competitive
position in the global market.

Er det noe nytt? “Svada” er vel en mer dekkende betegnelse. Observe har lovet “gull og grønne skoger” i flere år. Men har ikke levert noe som helst.

[Powertrade]

Ha en bedre dag

[Powertrade]

Nå begynner det å røre seg… Snart ser vi 1 krone- ca 100% opp dit…

[Powertrade]

Elsker Observe Medical- En fallert juvel som snart vil skinne igjen…

[Powertrade]

Herlig å være tidlig inne - Snart kommer bjellesauene…

[Quadruple]

Trodde det var du som var bjellesauen?

[Powertrade]

Ja - det ser slik ut- eller da er det bedre å kalles "bjelle lam "

[Powertrade]